SUPPORT PROGRAMME FOR PATIENTS RECEIVING IMRALDI OR BENEPALI THERAPY FOR IMMUNE-MEDIATED INFLAMMATORY DISORDERS: 12-MONTH PERSISTENCE

被引：0
|
作者：
Clark, Andrew [1 ]
Shering, Teresa [1 ]
Addison, Janet [2 ]
机构：
[1] Biogen Idec Ltd, Maidenhead, Berks, England
[2] Biogen Idec Ltd, Clin Res, Maidenhead, Berks, England
来源：
RHEUMATOLOGY | 2024年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P067
引用
收藏
页数：1
相关论文
共 50 条
  • [21] PLANNED INFLIXIMAB USE DURING PREGNANCY FOR PAKISTANI PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASE - CASE SERIES OF 12 PATIENTS
    Tayyab, Zaid
    Haroon, Mohammad
    RHEUMATOLOGY, 2024, 63
  • [22] Planned infliximab use during pregnancy for pakistani patients with immune-mediated inflammatory disease - case series of 12 patients
    Tayyab, Zaid
    Haroon, Mohammad
    RHEUMATOLOGY, 2024, 63
  • [23] IMPACT OF THE COVID-19 PANDEMIC ON PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES TAKING A BIOLOGIC THERAPY
    Halioua, B.
    Zetlaoui, J.
    Astruc, A.
    Testa, D.
    Bombezin-Domino, A.
    Radoszycki, L.
    VALUE IN HEALTH, 2020, 23 : S622 - S622
  • [24] COVID-19 vaccination in patients with immune-mediated inflammatory diseases receiving rituximab: A personalized regimen should be formulated
    Yang, Qian
    Jiang, Qi
    Niu, Man Man
    Fan, Guo Zhen
    Hu, Peng
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (01) : E45 - E46
  • [25] Severe enterovirus infections in patients with immune-mediated inflammatory diseases receiving anti-CD20 monoclonal antibodies
    de Fremont, Gregoire Martin
    Chabrolles, Helene
    Mirand, Audrey
    L'Honneur, Anne Sophie
    Mele, Nicolas
    Dunogue, Bertrand
    Boutboul, David
    Farhat, Meryem
    Hachulla, Eric
    Lazrek, Mouna
    Rieu, Virginie
    Mathian, Alexis
    Chaussade, Helene
    Ruet, Aurelie
    Burrel, Sonia
    Coury-Lucas, Fabienne
    Schuffenecker, Isabelle
    Lemaignen, Adrien
    Stefic, Karl
    le Besnerais, Maelle
    Carrette, Marion
    Mouthon, Luc
    Avettand-Fenoel, Veronique
    Terrier, Benjamin
    Hadjadj, Jerome
    RMD OPEN, 2024, 10 (02):
  • [26] Do tumor necrosis factor inhibitors increase cancer risk in patients with chronic immune-mediated inflammatory disorders?
    Chen, Yuehong
    Friedman, Marcia
    Liu, Gang
    Deodhar, Atul
    Chu, Cong-Qiu
    CYTOKINE, 2018, 101 : 78 - 88
  • [27] JAK Inhibitor Therapy in Refractory Uveitis Due to Immune-mediated Inflammatory Disorders. Multicenter Study and Literature Review
    Barroso Garcia, Nuria
    Sanchez Bilbao, Lara
    Martin Varillas, Jose Luis
    Calvo-Rio, Vanesa
    Esteban Ortega, Mar
    Munoz Fernandez, Santiago
    Alvarez Vega, Jose Luis
    Beltran Catalan, Emma
    Jovani, Vega
    Maiz Alonso, Olga
    Veroz Gonzalez, Raul
    Alvarez Reguera, Carmen
    Demetrio Pablo, Rosalia
    Blanco-Alonso, Ricardo
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2272 - 2274
  • [28] Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study
    Fautrel, Bruno
    Bouhnik, Yoram
    Salliot, Carine
    Carbonnel, Franck
    Fumery, Mathurin
    Bernardeau, Christophe
    Maugars, Yves
    Flamant, Mathurin
    Coury, Fabienne
    Braithwaite, Ben
    Hateb, Salima
    Addison, Janet
    DRUGS-REAL WORLD OUTCOMES, 2024, 11 (04) : 573 - 591
  • [29] CHARACTERIZATION OF THE IMMUNE RESPONSE IN PATIENTS WITH INFLAMMATORY IMMUNE-MEDIATED DISEASES ON IMMUNOSUPPRESSIVE TREATMENT AFTER ONE MONTH OF SARS-COV-2 VACCINATION
    Martinez-Feito, A.
    Nozal, P.
    Novella-Navarro, M.
    Fernandez-Fernandez, E.
    Molina, L. Del Pino
    Temprano, M. Casas
    Bousaid, I. Akatbach
    Arranz, M. D. Martin
    Balsa, A.
    Plasencia, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 374 - 374
  • [30] Clinical outcomes and immune reconstitution in 103 advanced AIDS patients undergoing 12-month highly active antiretroviral therapy
    DAI Yi QIU Zhifeng LI Taisheng HAN Yang ZUO Lingyan XIE Jing MA Xiaojun LIU Zhengyin and WANG AixiaDepartment of Infectious Diseases Peking Union Medical College Hospital Chinese Academy of Medical Sciences Peking Union Medical College Beijing China
    ChineseMedicalJournal, 2006, (20) : 1677 - 1682
12345